OXavidin for Tissue Targeting Biotinylated Therapeutics

Figure 5

Uptake of ¹¹¹In-ST2210, intravenously injected 48 hours after intramuscular administration of OXavidin or avidin in a limb. Groups of mice were sacrificed at the indicated time points after ¹¹¹In-ST2210 injection and samples of treated limb, spleen, liver, and kidney weighted and counted in a gamma counter. Data are expressed as % ID/g of tissue. Each point is the average of 5 mice. Bars represent standard deviation.

(a)

(b)

(c)

(d)